We are thrilled to announce Prof Muzlifah Haniffa @mhaniffa.bsky.social as our Plenary Speaker for this year's Annual Research Day! Muzz pioneers single-cell genomics to uncover how the human immune system develops and functions, advancing our understanding of tissue health, immunity and disease.
Medicine at Cambridge
@medcambridge.bsky.social
Updates on the latest research, news, and events from the Department of Medicine, University of Cambridge. Part of @cambridge-scm.bsky.social @cam.ac.uk Based on @cambridgebiocampus.bsky.social https://www.med.cam.ac.uk/
📢 Meet #BSICambridge26 speaker: Associate professor @pdncambridge.bsky.social @cam.ac.uk, Professor Milka Sarris will be speaking on trained immunity at the 2026 Cambridge Immunology Forum. 🎟️ Reserve your spot: buff.ly/x4pe1s9 @britsocimm.bsky.social
From welcoming our first cohort of Graduate Medicine students in 2001 to opening landmark institutes like #CITIID in 2019 & @vpd-hlri.bsky.social in 2022, we continue to advance education and research in medicine. Read more in @cambridge-scm.bsky.social 50th Anniversary Booklet:
The School of Clinical Medicine at 50 - School of Clinical Medicine 50th Anniversary
buff.ly
ICYMI: How Big Data and AI are revolutionizing human immunology
How Big Data and AI are revolutionizing human immunology
Nature Reviews Immunology, Published online: 23 July 2026; doi:10.1038/s41577-026-01340-zUnderstanding human biology in health and disease has entered a new era, one defined not just by better tools but by a fundamental shift in how biological knowledge is generated.
dlvr.it
Upcoming seminar: 🎓Dr Aude Bernheim @audeber.bsky.social, Head of Molecular Diversity Unit, Pasteur Institute @pasteur.fr 📢‘What bacteria teach us about immunity’ 📅4-5 PM, Thu 6 August 📍JCBC @cambridgebiocampus.bsky.social #CITIID
📢 Meet #BSICambridge26 speaker: @sarrazinsand.bsky.social Dr Sandrine Sarrazin from @ciml.bsky.social will be speaking on the immune journey of hematopoietic stem cells (HSCs) at the 2026 Cambridge Immunology Forum. 🎟️ Early bird registration still open: buff.ly/x4pe1s9 @britsocimm.bsky.social
📢 Meet #BSICambridge26 speaker: We're pleased to announce that Professor Maziar Divangahi (www.mcgill.ca) will speak on innate immune memory at the 2026 Cambridge Immunology Forum. 🎟️ Secure your early bird ticket: www.immunology.cam.ac.uk/events/cambr... @britsocimm.bsky.social
Upcoming seminar: 🎓Professor Ari Molofsky @arimolofskylab.bsky.social, Tissue Immunology Research Lab, @ucsanfrancisco.bsky.social 📢‘Barrier immune niches during microbial colonization and infection’ 📅1-2 PM, Thu 16 July 📍Max Perutz Lecture Theatre, @mrclmb.ac.uk @cambridgebiocampus.bsky.social
One month left to submit your abstract to the Cambridge Immunology Forum 2026! Hosted by @britsocimm.bsky.social and the Cambridge Immunology Network, this year we will be exploring parallels and intersections between different facets of immune memory. 🔗https://buff.ly/mbmFOEI #BSICambridge26
Upcoming seminar: 🎓Professor Anna Molofsky @annamolofskylab.bsky.social, Tissue Immunology Research Lab, @ucsanfrancisco.bsky.social 📢‘Interferon signaling in brain development and viral infection’ 📅4-5 PM, Thu 9 July 📍JCBC @cambridgebiocampus.bsky.social #CITIID
Join us as an NIHR Clinical Lecturer in Anaesthesia @cambridgebiocampus.bsky.social! This is an unrivalled opportunity to undertake high quality research within an outstanding academic and clinical environment. 📅 Apply by 29 July: buff.ly/K7FglCm #PACE @cam.ac.uk @cuh.nhs.uk
NIHR Clinical Lecturer in Anaesthesia
Applications are invited for a NIHR Clinical Lecturer in Anaesthesia (Department of Medicine) or Clinical Oncology (Department of Oncology) or Clinical Radiology (Department of Radiology). Based on…
cam.ac.uk
COVID-19 vaccine boosters may also protect against some future coronaviruses that risk spreading from animals to humans 💉 This research was conducted by Ravi Gupta and @medcambridge.bsky.social with support from the HKJC Global Health Institute 👏 Read more: https://bit.ly/4vz5fsZ
A team led by Professor Eoin McKinney at #CITIID showed that epilepsy drug sodium valproate could be repurposed to significantly boost the response to vaccines in humans, helping protect groups such as the elderly or immunocompromised. 🔗Now in @natcomms.nature.com: buff.ly/kC5mNwh @cam.ac.uk
Upcoming seminar: 🎓Dr Masahiro Ono @monotockylab.bsky.social, @imperialcollegeldn.bsky.social 📢‘Measuring Biological Time in T Cells: Integrated Experimental and Computational Approaches to Decoding Dynamic Immune Responses’ 📅4-5 PM, Thu 2 Jul 📍JCBC @cambridgebiocampus.bsky.social #CITIID
We're #hiring! Join the reception team @vpd-hlri.bsky.social and play a central front of house role in the day-to-day running of a busy research environment. Apply by 9 July: buff.ly/7mAqglr @cambridgebiocampus.bsky.social @cam.ac.uk
Upcoming seminar: 🎓Dr Leticia Monin Aldama, Department of Immunology and Inflammation, Faculty of Medicine @imperialcollegeldn.bsky.social 📢‘Normality versus stress-sensing by tissue-resident T cells’ 📅 4-5 PM, Thu 25 June 📍JCBC @cambridgebiocampus.bsky.social buff.ly/9PtbIn8 #CITIID
ATHENA, a major international coalition co-led by @cam.ac.uk & @stanfordmedicine.bsky.social has secured $9 million (~£6.7 million) from Leducq Foundation to develop new approaches for preventing heart attacks and strokes. 🔗 buff.ly/Cpl7Xbc @hellefjorgensen.bsky.social @vpd-hlri.bsky.social
£6.7 million global award to prevent cardiovascular disease | Department of Medicine
A major international coalition co-led by the University of Cambridge and Stanford Medicine has secured a grant of $9 million (approximately £6.7 million) to develop new approaches for predicting and…
buff.ly
Upcoming seminar: 🎓Professor James Davies @jojdavies.bsky.social @rdm.ox.ac.uk 📢‘Defining genome structure at base pair resolution’ 📅 3-4 PM, Thu 18 June 📍JCBC @cambridgebiocampus.bsky.social buff.ly/9PtbIn8 #CITIID
Register now for the 7th European Vasculitis Society International Vasculitis Educational Course! Designed for clinicians and trainees from a wide range of specialities, caring for patients with autoimmune disease. 📅 22-24 September 2026 📍 @jesuscollegecam.bsky.social 🔗
7th EUVAS Vasculitis Course 2026
The 7th EUVAS Vasculitis Course will take place at Jesus College, Cambridge, United Kingdom, from the 22nd to the 24th of September 2026. Find out more...
buff.ly
We are seeking 2️⃣ Postdoctoral Research Associates to work on Cambridge-GSK Translational Immunology Collaboration (CG-TIC) projects @cambridgebiocampus.bsky.social:
Our @clarebryant.bsky.social recently spoke to BBC Inside Science about Google Co-Scientist. Clare was given early access to Google's AI system to hunt for molecular switches that cause severe diseases in humans when pathogens leap between species. 🎧 Listen now on BBC Sounds:
BBC Inside Science - How is AI going to change science? - BBC Sounds
What role will humans play in the future of scientific research?
buff.ly
Upcoming seminar: 🎓Professor Greg Towers, Professor of Molecular Virology @qmul.bsky.social 📢‘Studying viruses to understand what makes pandemic viruses special and how innate immunity works’ 📅 4-5 PM, Thu 11 June 📍JCBC @cambridgebiocampus.bsky.social buff.ly/9PtbIn8 #CITIID
We are seeking an Operations Manager to lead and deliver the operational performance and long-term sustainability for our Cambridge Institute of Therapeutic Immunology and Infectious Disease (#CITIID). Find out more & apply today: buff.ly/yJg2GZ6 @cam.ac.uk @cambridgebiocampus.bsky.social
🚨 Fully funded PhD studentship opportunities at #CITIID 🚨 Join Professor Eoin McKinney to be a core part of CG-AGE, a collaborative project between @medcambridge.bsky.social and GSK, focused on the mechanisms and phenotypes of immune ageing. Apply by 18 June:
GlaxoSmithKline-funded PhD studentship: Immune Ageing (Fixed Term)
Applications are invited for fully funded, four-year PhD studentships based at the Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), within the Department of Medicine at…
buff.ly
Newly elected both as a Fellow of the @acmedsci.bsky.social and Fellow of the @royalsociety.org, John McCafferty has spent more than 3 decades transforming antibodies from natural defenders into medicines that have improved millions of lives. Read our latest feature on his journey: buff.ly/3GBB3Et
John McCafferty: The antibody pioneer
See the story
med.cam.ac.uk
Upcoming seminar: 🎓Dr Felix Randow @felixrandow.bsky.social, Director of Research 'Molecular Immunology’ @mrclmb.ac.uk 📢‘The role of non-protein ubiquitylation in innate immunity and brain homeostasis’ 📅 2-3 PM, Thu 28 May 📍JCBC @cambridgebiocampus.bsky.social buff.ly/9PtbIn8 #CITIID
Congratulations to Professor John McCafferty and Professor James Nathan @jamesnathanlab.bsky.social at #CITIID named as Fellows of the Academy of Medical Sciences @acmedsci.bsky.social today! Find out more about their work: www.citiid.cam.ac.uk/news/john-mc...
John McCafferty and James Nathan named as Fellows of 2026 Academy of Medical Sciences | Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID)
Professor John McCafferty and James Nathan have been recognised for their outstanding contributions to advancing medical science, each responsible for pioneering discovery research and translating inn...
citiid.cam.ac.uk
Congratulations to our 7 researchers announced today who have been elected to the Academy of Medical Sciences @acmedsci.bsky.social Fellowship! 🎉 Meet the Cambridge Fellows, recognised for their exceptional contributions to the biomedical and health sciences 👉 https://bit.ly/3PhiizD
🚨 Applications are still open for our fully funded @thebhf.bsky.social PhD Studentship🚨 Join our researchers @cam.ac.uk for a 4-year multidisciplinary programme tackling vascular disease. Apply by 28 May: buff.ly/xS32K8u @vpd-hlri.bsky.social
PhD Studentship - British Heart Foundation 4-Year Multidisciplinary Doctoral Training Programme: Secondary Prevention of Vascular Dysfunction and Disease
University of Cambridge, in collaboration with the University of Oxford Start date: October 2026 Fully funded studentships Applications are invited for a new British Heart Foundation (BHF) 4-Year
cam.ac.uk
More than 250,000 people in the UK live with Crohn's disease. The PROFILE trial, led by Prof Miles Parkes & Dr Nuru Noor at #CITIID, is setting a new global standard for treatment and care. Find out more: buff.ly/kWEgrkn @cam.ac.uk @cuh.nhs.uk @cambridgebrc.bsky.social
CITIID Research Highlight: Miles Parkes
See the story
buff.ly
Upcoming seminar: 🎓Professor Caetano Reis e Sousa @reisesousalab.bsky.social, Head of Immunobiology Laboratory @crick.ac.uk 📢‘DaNGeRous indigestion in dendritic cells and immunity to cancer’ 📅 4-5 PM, Thu 21 May 📍JCBC @cambridgebiocampus.bsky.social buff.ly/9PtbIn8 #CITIID